InvestorsHub Logo

Don'tDrinkTheKoolAid

01/16/19 9:41 AM

#172553 RE: jessellivermore #172551

Stop vascepa let us know if your DeS comes back?

retinadoc

01/16/19 9:50 AM

#172563 RE: jessellivermore #172551

http://www.visionmonday.com/latest-news/article/shire-reports-sales-growth-of-6-percent-in-q2-as-xiidra-hits-100-million-in-sales/

DES is big money and a reoccurring revenue stream. Unlike Reduce-it this would be a very easy/quick study for Amarin to do. This is Zip's expertise, but the results of tear film production and composition are quantifiable. I would think all you would need is 6 months at most on Vascepa to see changes.

I hope someone at AMRN is mining the Reduce-it data for diabetic retinopathy, macular degeneration, and vein occlusion data. The association of mac degeneration with C- reactive protein is absolute, and is likely serving as an inflammatory marker as trigs did in reduce-it.

biowreck

01/16/19 9:53 AM

#172566 RE: jessellivermore #172551

JL...eviscerate V just cause it hasn’t helped me with des? Sorry but I’m not gonna pump V for the wrong reasons. Btw, my blood work results came in yesterday and results were outstanding. But I’m not gonna say my PSA levels have dropped because of V either. But your clueless if you think I’ve been hangin on this stock all these years and not long lol.